Context Therapeutics Inc. (CNTX) stock

CNTXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30

$0.18−0.02 (-8.69%)

Close on Nov 13, 2026Market cap $16.61MP/E –Yield –

Context Therapeutics statistics

65 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $16.61M; $272.32M
Enterprise Value: -$17.80M; $146.23M
PB Ratio: 0.54; 2.00
P/TBV Ratio: 0.54; 2.22

Share statisticsIndustry

Shares Outstanding: 92M; 58M
Shares Change (YoY): 3.60%; 10.8%
Shares Change (QoQ): 0.00%; 0.50%
Float: 90M; 49M
Shares Held by Insiders: 1.92%; 11.7%
Shares Held by Institutions: 68.4%; 56.4%

Short sellingIndustry

Short Interest: 5M; –
Short Interest Change: 9.90%; -0.80%
Short % of Float: 5.21%; 9.01%
Short % of Shares Outstanding: 5.11%; 6.30%
Days to Cover: 3.68; 5.15

Stock price statisticsIndustry

52-Week High: $3.62; –
52-Week Low: $0.18; –
20-Day Moving Average: $0.21; –
50-Day Moving Average: $0.28; –
200-Day Moving Average: $1.37; –
Average True Range (14): $0.02; –
Price Change (1 Week): -6.56%; -1.15%
Price Change (1 Month): -24.8%; -4.87%
Price Change (3 Months): -65.9%; -21.0%
Price Change (6 Months): -91.6%; -20.6%
Price Change (YTD): -87.7%; -23.6%
Price Change (1 Year): -84.7%; -22.4%
Price Change (3 Years): -82.1%; -29.5%
Price Change (5 Years): -96.7%; -77.9%
Average Volume (10 Days): 2M; –
Average Volume (20 Days): 1M; –
Average Volume (90 Days): 2M; –
Relative Volume: 0.55; 0.70
Relative Strength Index (14): 34.3; 43.4
Volatility (1 Year): 104.9%; 80.1%
Beta (5 Years): 1.27; 1.07

Returns on capitalIndustry

Return on Equity (ROE): -84.3%; -49.9%
Return on Assets (ROA): -75.8%; -40.6%
Return on Capital Employed (ROCE): -148.5%; -37.9%

Financial positionIndustry

Current Ratio: 6.59; 3.30
Quick Ratio: 6.26; 2.39

EfficiencyIndustry

Profits Per Employee: -$2.93M; -$689.41K
Employee Count: 15; 74
WACC: 11.4%; 10.2%

Income statement (TTM)Industry

Operating Income: -$46.08M; -$21.37M
Net Income: -$43.89M; -$22.35M
EBITDA: -$46.05M; -$17.21M
EPS (Diluted): -$0.46; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $34.41M; $68.68M
Net Cash (Debt): $34.41M; $17.76M
Net Cash Per Share: $0.37; $0.80
Equity (Book Value): $31.01M; $53.89M
Book Value Per Share: $0.34; $1.50
Tangible Book Value: $31.01M; $27.13M
Working Capital: $30.77M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$33.97M; -$12.38M
Capital Expenditures: -$55.75K; -$1.00M
Free Cash Flow: -$34.03M; -$18.21M
FCF Per Share: -$0.37; -$0.42

Dividends and yieldsIndustry

Earnings Yield: -264.2%; -21.8%
FCF Yield: -204.8%; -9.44%
Buyback Yield: -0.09%; -0.76%
Shareholder Yield: -0.09%; 0.00%

Scores and fair valueIndustry

Altman Z-Score: -7.55; 0.23
Piotroski F-Score: 3; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	CNTX	S&P 500	Difference	CNTX per year	S&P 500 per year
1 month	-34.3%	-3.0%	−31.2 pts
3 months	-64.3%	-2.8%	−61.5 pts
Year to date	-87.7%	+11.5%	−99.2 pts
1 year	-84.3%	+13.5%	−97.7 pts
3 years	-82.8%	+77.7%	−160.5 pts	-44.4%	+21.1%
5 years	-96.7%	+72.6%	−169.3 pts	-49.3%	+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

5M CNTX shares were sold short on Oct 30, 2026, up 9.9% from the previous report, or 5.21% of the shares available to trade. At recent volumes it would take 3.7 days to buy them back. Over the last 20 sessions, 44.1% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	4,695,883	+9.9%	1,277,032	3.7
Oct 15, 2026	4,272,977	-9.2%	841,238	5.1
Sep 30, 2026	4,707,944	-31.8%	1,169,248	4.0
Sep 15, 2026	6,907,157	+6.8%	1,209,528	5.7
Aug 31, 2026	6,466,057	+3.1%	2,581,449	2.5
Aug 14, 2026	6,272,254	+7.6%	1,998,477	3.1
Jul 31, 2026	5,830,527	-12.1%	1,378,947	4.2
Jul 15, 2026	6,630,017	+106.5%	3,660,812	1.8
Jun 30, 2026	3,211,049	+275.7%	4,938,871	1.0
Jun 15, 2026	854,672	-4.6%	2,428,010	1.0
May 29, 2026	896,056	-2.6%	826,612	1.1
May 15, 2026	920,211	+2.4%	514,923	1.8

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?